Literature DB >> 27497143

Detecting intrinsic muscle weakness of the hallux as an addition to early-stage screening of the feet in patients with diabetes.

R Mahieu1, M N O Coenen1, T van Bemmel2, H J van der Zaag-Loonen3, W J Theuvenet4.   

Abstract

AIMS: Present-day screening of the diabetic foot involves the Semmes Weinstein Monofilament Test for evaluating loss of sensibility, while testing for intrinsic muscle weakness is not implied. Just as with the early detection of sensibility loss, early detection of intrinsic muscle weakness might have important implications for the prevention of both ulceration and deformity in patients with diabetes. The purpose of this study is to investigate the prevalence of patients with diabetes presenting intrinsic muscle weakness of the hallux, but with a normal sensibility of the sole of the foot.
METHODS: A cross-sectional study design was applied. Intrinsic muscle function of the hallux was measured with the Paper Grip Test, while sensibility of the sole of the foot was measured with the Semmes Weinstein Monofilament Test 5.07/10-g.
RESULTS: In a period of three months a total of 266 patients with diabetes (mean age 60, 134 females (50%), 177 type 2 diabetes mellitus (67%)) met the inclusion criteria and were examined for both intrinsic muscle weakness of the hallux and sensibility of the soles of the feet. The results showed that intrinsic muscle weakness was present more frequent in patients with impaired sensibility (P=0.001), also 20% of the population had intrinsic muscle weakness in the presence of normal sensibility. Multivariate regression analysis showed that only age is associated with patients with diabetes presenting normal sensibility but impaired intrinsic muscle function (P=0.017).
CONCLUSIONS: The Paper Grip Test could have added value to current physical examination of the feet in patients with diabetes.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Diabetic; Foot; Grip; Paper; Test

Mesh:

Year:  2016        PMID: 27497143     DOI: 10.1016/j.diabres.2016.07.007

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  3 in total

1.  Sarcopenia is independently associated with diabetic foot disease.

Authors:  Qingfeng Cheng; Jinbo Hu; Ping Yang; Xueting Cao; Xuefeng Deng; Qin Yang; Zhiping Liu; Shumin Yang; Richa Goswami; Yue Wang; Ting Luo; Kun Liao; Qifu Li
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

2.  Foot-ankle functional outcomes of using the Diabetic Foot Guidance System (SOPeD) for people with diabetic neuropathy: a feasibility study for the single-blind randomized controlled FOotCAre (FOCA) trial I.

Authors:  Ronaldo H Cruvinel Júnior; Jane S S P Ferreira; Raquel I Beteli; Érica Q Silva; Jady L Veríssimo; Renan L Monteiro; Eneida Y Suda; Isabel C N Sacco
Journal:  Pilot Feasibility Stud       Date:  2021-03-26

3.  Multi-System Factors Associated with Metatarsophalangeal Joint Deformity in Individuals with Type 2 Diabetes.

Authors:  Jennifer A Zellers; Michael J Mueller; Paul K Commean; Ling Chen; Hyo-Jung Jeong; Mary K Hastings
Journal:  J Clin Med       Date:  2020-04-03       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.